Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Interest Expenses (2016 - 2025)

Palisade Bio (PALI) has disclosed Interest Expenses for 16 consecutive years, with $5000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Expenses fell 16.67% to $5000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $11000.0, a 15.38% decrease, with the full-year FY2024 number at $12000.0, down 20.0% from a year prior.
  • Interest Expenses was $5000.0 for Q3 2025 at Palisade Bio, up from $2000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.7 million in Q1 2021 to a low of $1000.0 in Q1 2022.
  • A 5-year average of $111562.5 and a median of $3500.0 in 2022 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: surged 66243.54% in 2021, then tumbled 99.94% in 2022.
  • Palisade Bio's Interest Expenses stood at $26000.0 in 2021, then crashed by 88.46% to $3000.0 in 2022, then skyrocketed by 33.33% to $4000.0 in 2023, then dropped by 25.0% to $3000.0 in 2024, then soared by 66.67% to $5000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Interest Expenses are $5000.0 (Q3 2025), $2000.0 (Q2 2025), and $1000.0 (Q1 2025).